Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme

We ask healthcare professionals to support new guidance for users of diabetes management equipment, their families, care givers and representatives.

This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.